association (references)

References for: association

Full identifier: http://purl.org/np/RA_YLsU-_9ReKinT_QyJOHbLAlnnvrAt6dPA37DgUQxRc#association

Nanopublication	Part	Subject	Predicate	Object	Published By	Published On
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#type type	http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement	Leoni Bücken	2021-06-30T07:26:54.277Z
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/2000/01/rdf-schema#label label	acromegaly octreotide acetate injection is indicated to reduce blood levels of growth hormone and igf i somatomedin c in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection pituitary irradiation and bromocriptine mesylate at maximally tolerated doses the goal is to achieve normalization of growth hormone and igf i somatomedin c levels see dosage and administration improvement in clinical signs and symptoms or reduction in tumor size or rate of growth were not shown in clinical trials performed with octreotide acetate injection these trials were not optimally designed to detect such effects carcinoid tumors octreotide acetate injection is indicated for the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses or inhibits the severe diarrhea and flushing episodes associated with the disease octreotide acetate injection studies were not designed to show an effect on the size rate of growth or development of metastases vasoactive intestinal peptide tumors vipomas octreotide acetate injection is indicated for the treatment of the profuse watery diarrhea associated with vip secreting tumors octreotide acetate injection studies were not designed to show an effect on the size rate of growth or development of metastases	Leoni Bücken	2021-06-30T07:26:54.277Z
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#object object	http://purl.obolibrary.org/obo/DOID_2449 DOID_2449	Leoni Bücken	2021-06-30T07:26:54.277Z
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate	https://w3id.org/biolink/vocab/treats treats	Leoni Bücken	2021-06-30T07:26:54.277Z
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject	https://identifiers.org/drugbank:DB00104 drugbank:DB00104	Leoni Bücken	2021-06-30T07:26:54.277Z
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/association_type association_type	https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation	Leoni Bücken	2021-06-30T07:26:54.277Z
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/provided_by provided_by	https://w3id.org/um/NeuroDKG NeuroDKG	Leoni Bücken	2021-06-30T07:26:54.277Z
http://purl.org/np/RA_YLsU-_9... RA_YLsU-_9	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/relation relation	https://w3id.org/um/neurodkg/SymptomaticReliefIndication SymptomaticReliefIndication	Leoni Bücken	2021-06-30T07:26:54.277Z